N-[2-[2-[4-(1,2-benzoxazol-3-yl)piperazin-1-yl]ethyl]-4-fluorophenyl]-3-methylbut-2-enamide
C24H27FN4O2 — CID 91606612
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[2-[4-(1,2-benzoxazol-3-yl)piperazin-1-yl]ethyl]-4-fluorophenyl]-3-methylbut-2-enamide
N-[2-[2-[4-(1,2-benzoxazol-3-yl)piperazin-1-yl]ethyl]-4-fluorophenyl]-3-methylbut-2-enamide (PubChem CID 91606612) has the molecular formula C24H27FN4O2 and a molecular weight of 422.50 g/mol. Its IUPAC name is N-[2-[2-[4-(1,2-benzoxazol-3-yl)piperazin-1-yl]ethyl]-4-fluorophenyl]-3-methylbut-2-enamide.
Molecular Properties
| Compound Name | N-[2-[2-[4-(1,2-benzoxazol-3-yl)piperazin-1-yl]ethyl]-4-fluorophenyl]-3-methylbut-2-enamide |
|---|---|
| PubChem CID | 91606612 |
| Molecular Formula | C24H27FN4O2 |
| Molecular Weight | 422.50 g/mol |
| Exact Mass | 422.21 |
| IUPAC Name | N-[2-[2-[4-(1,2-benzoxazol-3-yl)piperazin-1-yl]ethyl]-4-fluorophenyl]-3-methylbut-2-enamide |
| SMILES | CC(C)=CC(=O)Nc1ccc(F)cc1CCN1CCN(c2noc3ccccc23)CC1 |
| InChI | InChI=1S/C24H27FN4O2/c1-17(2)15-23(30)26-21-8-7-19(25)16-18(21)9-10-28-11-13-29(14-12-28)24-20-5-3-4-6-22(20)31-27-24/h3-8,15-16H,9-14H2,1-2H3,(H,26,30) |
| InChIKey | ZPNIHYQEOZGQJC-UHFFFAOYSA-N |
| XLogP | 4.24 |
| TPSA | 61.61 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 422.50 |
| LogP ≤ 5 | 4.24 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91606612 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.